International Journal of Therapeutic Applications

ISSN 2320-138X (online)                   ISSN 2455-4235 (Print)
Cites per doc / Impact factor: 0.86

International Journal of Therapeutic Applications (IJTA) provides quality publication of articles in all areas of Medical, Pharmaceutical and Biological Science. The Journal accepts articles that meet the general criteria of relevance to journals objectives and scientific excellence. All articles published in IJTA will be peer-reviewed.

International Journal of Therapeutic Applications is dedicated for publication of quality research and review articles that have promising therapeutic applications. The Editors and Editorial board seek that the authors mention in brief the Therapeutic Applicability of their research in the accompanying cover letter.

Areas covered: Ayurveda, Biochemistry, Biochemistry related to Bioassays, Bioinformatics, Biotechnology, Chemistry, Clinical Pharmacy, Clinical Research, Community Pharmacy, Genetics, Health Care Management, Herbal formulation, Hospital Management, Hospital Pharmacy, Immunology, Medical & health sciences , Medical research, Microbiology, Pharmaceutical Analysis, Pharmaceutical Biotechnology, Pharmaceutical Chemistry, Pharmaceutical Microbiology, Pharmaceutical Sciences, Pharmaceutics, Pharmacognosy, Pharmacology, Pharmacotherapeutics , Pharmacovigilance, Pharmacy Practice , Physiotherapy, Phytochemistry, Quality Assurance, Regulatory Affairs

Journal Indexing & Impact Factor: Under process
Open-J-Gate, Google, Google scholar, Ayush Research portal Hinari- WHO, Directory of open access journals (DOAJ), Chemical Abstract, Gale- Expanded Academic ASAP, International consortium for the advancement of academic publication (ICAAP), Scientific common, Pharmaceutical Sciences Open Access Resources (PSOAR), Index Copernicus, Ulrich’s International Periodical Directory, ProQuest, New York University Health Sciences Libraries, Research Gate, Geneva Foundation for Medical Education & Research and Genamics Journal Seek.
The journal is also under ELSEVIER review.

Impact Factor: Under process for SCOPUS, EMBASE, EBSCO, SCI, PUBMED